| Title |
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
|
|---|---|
| Published in |
Cancer Chemotherapy and Pharmacology, January 2013
|
| DOI | 10.1007/s00280-012-2055-z |
| Pubmed ID | |
| Authors |
Robert L. Fine, Anthony P. Gulati, Benjamin A. Krantz, Rebecca A. Moss, Stephen Schreibman, Dawn A. Tsushima, Kelley B. Mowatt, Richard D. Dinnen, Yuehua Mao, Peter D. Stevens, Beth Schrope, John Allendorf, James A. Lee, William H. Sherman, John A. Chabot |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| France | 1 | <1% |
| Unknown | 103 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 14% |
| Other | 13 | 12% |
| Student > Ph. D. Student | 13 | 12% |
| Student > Postgraduate | 9 | 8% |
| Professor | 7 | 7% |
| Other | 27 | 25% |
| Unknown | 22 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 55% |
| Nursing and Health Professions | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Agricultural and Biological Sciences | 2 | 2% |
| Computer Science | 2 | 2% |
| Other | 13 | 12% |
| Unknown | 25 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2023.
All research outputs
#15,810,483
of 26,017,215 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#1,828
of 2,608 outputs
Outputs of similar age
#177,133
of 297,029 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#21
of 32 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,608 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,029 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.